Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.

Title
Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 10, Issue Supplement 1, Pages A249-A249
Publisher
American Association for Cancer Research (AACR)
Online
2012-06-27
DOI
10.1158/1535-7163.targ-11-a249

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now